Genotype-phenotype correlation for pulmonary function in cystic ribrosis

Thorax

Volumn 60, Issue 7, 2005, Pages 558-563

  De Gracia, J ^a,b   Mata, F ^b,c   Alvarez A ^b   Casals, T ^d   Gatner, S ^b   Vendrell, M ^e   De La Rosa, D ^b   Guarner, L ^b   Hermosilla, E ^b  

^a Hospital General Vall d'Hebron ^*  (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL DURAN I REYNALS   (Spain)

^e HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; CELL SURFACE; CHROMOSOME MUTATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE SEVERITY; EPITHELIUM CELL; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SPIROMETRY; SURVIVAL RATE;

ADULT; ANALYSIS OF VARIANCE; COHORT STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; MALE; MUTATION; PHENOTYPE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VITAL CAPACITY;

EID: 22044438841     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.031153     Document Type: Article

References (34)

1. Gartner S, Cobos N, et al. Neonatal screening for cystic fibrosis in Catalunya, Spain. Pediatr Pulmonol 2003;36(Suppl 25):P221.
2. Ratjen F, Döring G. Cystic fibrosis. Lancet 2003;361:681-9.
3. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187-91.
4. Rowntree R, Harris A. The phenotypic consequences of CFTR mutations. Ann Hum Genet 2003;67:471-85.
5. Jentsch TJ, Stein V, Weinreich F, et al. Molecular structure and physiological function of chloride channels. Physiol Rev 2002;82:503-68.
6. Boucher RC. An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev 2002;54:1359-71.
7. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
8. Cystic Fibrosis Mutation Database. The Cystic Fibrosis Genetic Analysis Consortium, www.genet.sickkids.on.ca/cftr/.
9. Welsh MJ, Smith AE. Molecular mechanism of CFTR chloride channels dysfunction in cystic fibrosis. Cell 1993;73:1251-4.
10. Vankeerfaerghen A, Cuppens H, Casiman JJ. The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions. J Cystic Fibrosis 2002;1:13-29.
11. Chillion M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995;332:1475-80.
12. The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993;329:1308-13.
13. Gan KH, Veeze HJ, van den Ouweland AM, et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med 1995;333:95-9.
14. Kerem E, Kerem B. Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 1996;22:387-95.
15. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998;132:589-95.
16. Modolell I, Alvarez A, Guarner L, et al. Gatrointestinal, liver and pancreatic involvement in adult patients with cystic fibrosis. Pancreas 200, 22:395-9.
17. Roca J, Burgos F, Sunyer J, et al. References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J 1998;11:1354-62.
18. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
19. Casals T, De Gracia J, Gallego M, et al. Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations? Clin Genet 2004;65:490-5.
20. Casals T, Ramos MD, Gimenez J, et al. High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes. Hum Genet 1997;101:365-70.
21. Tsui LC, Durie P. Genotype and phenotype in cystic fibrosis. Hosp Pract 1997;32:115-34.
22. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51.
23. Schlechter MS, Shelton BJ, et al. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001;163:1331-7.
24. Hull J, Thomson HA. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 1998;53:1018-21.
25. Arkwright PD, Laurie S, Super M, et al. TGF-genotype and accelerated decline in lung function of patients with cystic ribrosis. Thorax 2000;55:459-62.
26. Stern RC, Doershuk CF, Drumm ML 3849+10 kb C → T mutation and disease severity in cystic fibrosis. Lancet 1995;346:274-6.
27. Highsmith WE Jr, Burch LH, Zhou Z, et al. Identification of a splice site mutation (2789 +5G>A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis. Hum Mutat 1997;9:332-8.
28. Gilfillan A, Warner JP, Kirk JM, et al. P67L: a cystic fibrosis allele with mild effects found at high frequency in the Scottish population. J Med Genet 1998;35:122-5.
29. Loubieres Y, Grenet D, Simon-Bouy B, et al. Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients. Chest 2002;121:73-80.
30. McKone EF, Emerson SS, Edwards KL, et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003;361:1671-6.
31. De Gracia J, Urrutia A, Guarga A, et al. Cystic fibrosis in adults (in Spanish). Med Clin (Barc) 1984;83:392-3.
32. De Gracia J, Alvarez A, Mata F, et al. Cystic fibrosis in adults: study of 111 patients (in Spanish). Med Clin (Barc) 2002;119:605-9.
33. Kerem E, Nissim-Rafinia M, Argaman Z, et al. A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype. Pediatrics 1997;100:E5.
34. Fanen P, Clain J, Labarthe R, et al. Structure-function analysis of a double-mutant cystic fibrosis transmembrane conductance regulator protein occurring in disorders related to cystic fibrosis. FEBS Lett 1999;452:371-4.